_id
6913002dccc777a4e85d78b4
Ticker
IFRX
Name
InflaRx N.V.
Exchange
NASDAQ
Address
Winzerlaer Str. 2, Jena, Germany, 07745
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.inflarx.de
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase III clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; for the treatment of anti-neutrophil cytoplasm antibody associated vasculitis, a rare and life-threatening autoimmune disease that is in Phase II trial; to treat pyoderma gangraenosum, a chronic inflammatory skin disorder that is in Phase IIa exploratory study; and for the treatment of PD-1/PD-L1 inhibitor resistant/refractory locally advanced or metastatic cutaneous squamous cell carcinoma that is in Phase II clinical development stage. The company develops INF904, an oral, small molecule drug candidate for the chronic inflammatory and autoimmune diseases; IFX002 that is in pre-clinical development stage for the treatment of chronic inflammation and autoimmune diseases; and Gohibic (vilobelimab) for the treatment of COVID-19 and broader ARDS. It has co-development agreement with Beijing Defengrei Biotechnology Co. Ltd.; and clinical trial collaboration and supply agreement with Merck & Co. Inc. InflaRx N.V. was formerly known as Fireman B.V. and changed its name to InflaRx N.V. in 2017. The company was founded in 2007 and is headquartered in Jena, Germany.
Last Close
1
Volume
611400
Current Price
1.03
Change
3.0000000000000027
Last Updated
2025-12-01T09:13:28.878Z
Image
data:image/webp;base64,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
Ipo Date
2017-11-08T00:00:00.000Z
Market Cap
85361384
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.663
Sentiment Sources
4
Rating
4.5714
Target Price
11.6284
Strong Buy
5
Buy
1
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
23830
Cost Of Revenue
333
Gross Profit
23497
Operating Expenses
9500501
Operating Income
-9477004
Interest Expense
14359
Pretax Income
-12248808
Net Income
-12261089
Eps
-0.18000000029361177
Dividends Per Share
-
Shares Outstanding
67747130
Income Tax Expense
12282
EBITDA
-12134656
Operating Margin
-39769.215274863614
Total Other Income Expense Net
-2771804
Cash
6448117
Short Term Investments
38197197
Receivables
-
Inventories
5071345
Total Current Assets
63467015
Property Plant Equipment
1242021
Total Assets
65157050
Payables
9228118
Short Term Debt
270718
Long Term Debt
-
Total Liabilities
19790235
Equity
45366815
Depreciation
99793
Change In Working Capital
-258133
Cash From Operations
-9039961
Capital Expenditures
87972
Cash From Investing
2603882
Cash From Financing
-84953
Net Change In Cash
-6555333
PE
-
PB
1.5465197596525126
ROE
-27.02655895063385
ROA
-18.81774727370254
FCF
-9127933
Fcf Percent
-383.0437683592111
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
5
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
23830
Quarters > 0 > income Statement > cost Of Revenue
333
Quarters > 0 > income Statement > gross Profit
23497
Quarters > 0 > income Statement > operating Expenses
9500501
Quarters > 0 > income Statement > operating Income
-9477004
Quarters > 0 > income Statement > interest Expense
14359
Quarters > 0 > income Statement > pretax Income
-12248808
Quarters > 0 > income Statement > net Income
-12261089
Quarters > 0 > income Statement > eps
-0.18000000029361177
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
68117161
Quarters > 0 > income Statement > income Tax Expense
12282
Quarters > 0 > income Statement > EBITDA
-12134656
Quarters > 0 > income Statement > operating Margin
-39769.215274863614
Quarters > 0 > income Statement > total Other Income Expense Net
-2771804
Quarters > 0 > balance Sheet > cash
6448117
Quarters > 0 > balance Sheet > short Term Investments
38197197
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
5071345
Quarters > 0 > balance Sheet > total Current Assets
63467015
Quarters > 0 > balance Sheet > property Plant Equipment
1242021
Quarters > 0 > balance Sheet > total Assets
65157050
Quarters > 0 > balance Sheet > payables
9228118
Quarters > 0 > balance Sheet > short Term Debt
270718
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
19790235
Quarters > 0 > balance Sheet > equity
45366815
Quarters > 0 > cash Flow > net Income
-12261089
Quarters > 0 > cash Flow > depreciation
99793
Quarters > 0 > cash Flow > change In Working Capital
-258133
Quarters > 0 > cash Flow > cash From Operations
-9039961
Quarters > 0 > cash Flow > capital Expenditures
87972
Quarters > 0 > cash Flow > cash From Investing
2603882
Quarters > 0 > cash Flow > cash From Financing
-84953
Quarters > 0 > cash Flow > net Change In Cash
-6555333
Quarters > 0 > ratios > PE
-0.18000000029361177
Quarters > 0 > ratios > PB
1.5465197596525126
Quarters > 0 > ratios > ROE
-27.02655895063385
Quarters > 0 > ratios > ROA
-18.81774727370254
Quarters > 0 > ratios > FCF
-9127933
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-383.0437683592111
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
39432
Quarters > 1 > income Statement > cost Of Revenue
2399583
Quarters > 1 > income Statement > gross Profit
-2360151
Quarters > 1 > income Statement > operating Expenses
10557837
Quarters > 1 > income Statement > operating Income
-12917988
Quarters > 1 > income Statement > interest Expense
3355
Quarters > 1 > income Statement > pretax Income
-14323438
Quarters > 1 > income Statement > net Income
-14416271
Quarters > 1 > income Statement > eps
-0.21279530217737638
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
67747130
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-14205083
Quarters > 1 > income Statement > operating Margin
-32760.164333536217
Quarters > 1 > income Statement > total Other Income Expense Net
-1405450
Quarters > 1 > balance Sheet > cash
13003450
Quarters > 1 > balance Sheet > short Term Investments
34993289
Quarters > 1 > balance Sheet > receivables
1753638
Quarters > 1 > balance Sheet > inventories
5038415
Quarters > 1 > balance Sheet > total Current Assets
66172692
Quarters > 1 > balance Sheet > property Plant Equipment
806313
Quarters > 1 > balance Sheet > total Assets
73442172
Quarters > 1 > balance Sheet > payables
9735656
Quarters > 1 > balance Sheet > short Term Debt
395234
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
16397807
Quarters > 1 > balance Sheet > equity
57044365
Quarters > 1 > cash Flow > net Income
-14416271
Quarters > 1 > cash Flow > depreciation
115000
Quarters > 1 > cash Flow > change In Working Capital
3371661
Quarters > 1 > cash Flow > cash From Operations
-7553095
Quarters > 1 > cash Flow > capital Expenditures
15227
Quarters > 1 > cash Flow > cash From Investing
-24906435
Quarters > 1 > cash Flow > cash From Financing
-99575
Quarters > 1 > cash Flow > net Change In Cash
-34283180
Quarters > 1 > ratios > PE
-0.21279530217737638
Quarters > 1 > ratios > PB
1.2232504279782936
Quarters > 1 > ratios > ROE
-25.27203344274233
Quarters > 1 > ratios > ROA
-19.629418095096643
Quarters > 1 > ratios > FCF
-7568322
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-191.9335057821059
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
9291
Quarters > 2 > income Statement > gross Profit
-9291
Quarters > 2 > income Statement > operating Expenses
12995848
Quarters > 2 > income Statement > operating Income
-13005139
Quarters > 2 > income Statement > interest Expense
4086
Quarters > 2 > income Statement > pretax Income
-8314025
Quarters > 2 > income Statement > net Income
-8314027
Quarters > 2 > income Statement > eps
-0.1313164545537955
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
63312911
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-8196138
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
4691114
Quarters > 2 > balance Sheet > cash
47286631
Quarters > 2 > balance Sheet > short Term Investments
18573783
Quarters > 2 > balance Sheet > receivables
1693150
Quarters > 2 > balance Sheet > inventories
6895371
Quarters > 2 > balance Sheet > total Current Assets
85611597
Quarters > 2 > balance Sheet > property Plant Equipment
905684
Quarters > 2 > balance Sheet > total Assets
87000103
Quarters > 2 > balance Sheet > payables
8366404
Quarters > 2 > balance Sheet > short Term Debt
407184
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
16534396
Quarters > 2 > balance Sheet > equity
70465708
Quarters > 2 > cash Flow > net Income
-8314027
Quarters > 2 > cash Flow > depreciation
113801
Quarters > 2 > cash Flow > change In Working Capital
-5251475
Quarters > 2 > cash Flow > cash From Operations
-14015672
Quarters > 2 > cash Flow > capital Expenditures
10446
Quarters > 2 > cash Flow > cash From Investing
17655632
Quarters > 2 > cash Flow > cash From Financing
27009268
Quarters > 2 > cash Flow > net Change In Cash
28910651
Quarters > 2 > ratios > PE
-0.1313164545537955
Quarters > 2 > ratios > PB
0.925447287494791
Quarters > 2 > ratios > ROE
-11.79868511361583
Quarters > 2 > ratios > ROA
-9.556341559733555
Quarters > 2 > ratios > FCF
-14026118
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
41
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
-423
Quarters > 3 > income Statement > cost Of Revenue
2820920
Quarters > 3 > income Statement > gross Profit
-2821343
Quarters > 3 > income Statement > operating Expenses
6942129
Quarters > 3 > income Statement > operating Income
-9763472
Quarters > 3 > income Statement > interest Expense
4779
Quarters > 3 > income Statement > pretax Income
-5111772
Quarters > 3 > income Statement > net Income
-5111772
Quarters > 3 > income Statement > eps
-0.08681195569430993
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
58883272
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-4996256
Quarters > 3 > income Statement > operating Margin
2308149.408983452
Quarters > 3 > income Statement > total Other Income Expense Net
4651700
Quarters > 3 > balance Sheet > cash
18375979
Quarters > 3 > balance Sheet > short Term Investments
34462352
Quarters > 3 > balance Sheet > receivables
1735335
Quarters > 3 > balance Sheet > inventories
6897666
Quarters > 3 > balance Sheet > total Current Assets
71656506
Quarters > 3 > balance Sheet > property Plant Equipment
1014648
Quarters > 3 > balance Sheet > total Assets
76018457
Quarters > 3 > balance Sheet > payables
3413064
Quarters > 3 > balance Sheet > short Term Debt
406020
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
14602418
Quarters > 3 > balance Sheet > equity
61416039
Quarters > 3 > cash Flow > net Income
-5111772
Quarters > 3 > cash Flow > depreciation
110737
Quarters > 3 > cash Flow > change In Working Capital
-2782196
Quarters > 3 > cash Flow > cash From Operations
-11894800
Quarters > 3 > cash Flow > capital Expenditures
16879
Quarters > 3 > cash Flow > cash From Investing
1956391
Quarters > 3 > cash Flow > cash From Financing
676591
Quarters > 3 > cash Flow > net Change In Cash
-7829959
Quarters > 3 > ratios > PE
-0.08681195569430993
Quarters > 3 > ratios > PB
0.987523310645286
Quarters > 3 > ratios > ROE
-8.32318736804241
Quarters > 3 > ratios > ROA
-6.724382737734337
Quarters > 3 > ratios > FCF
-11911679
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
28159.997635933807
Quarters > 3 > health Score
51
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
165789
Annuals > 0 > income Statement > cost Of Revenue
3317039
Annuals > 0 > income Statement > gross Profit
-3151250
Annuals > 0 > income Statement > operating Expenses
49857614
Annuals > 0 > income Statement > operating Income
-53008864
Annuals > 0 > income Statement > interest Expense
20655
Annuals > 0 > income Statement > pretax Income
-46059186
Annuals > 0 > income Statement > net Income
-46064402
Annuals > 0 > income Statement > eps
-0.7818302033185469
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
58918678
Annuals > 0 > income Statement > income Tax Expense
5217
Annuals > 0 > income Statement > EBITDA
-45553417
Annuals > 0 > income Statement > operating Margin
-31973.691861341824
Annuals > 0 > income Statement > total Other Income Expense Net
6949678
Annuals > 0 > balance Sheet > cash
18375979
Annuals > 0 > balance Sheet > short Term Investments
34462352
Annuals > 0 > balance Sheet > receivables
1735335
Annuals > 0 > balance Sheet > inventories
6897666
Annuals > 0 > balance Sheet > total Current Assets
71656506
Annuals > 0 > balance Sheet > property Plant Equipment
1014648
Annuals > 0 > balance Sheet > total Assets
76018457
Annuals > 0 > balance Sheet > payables
3413064
Annuals > 0 > balance Sheet > short Term Debt
406020
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
14602418
Annuals > 0 > balance Sheet > equity
61416039
Annuals > 0 > cash Flow > net Income
-46064402
Annuals > 0 > cash Flow > depreciation
485114
Annuals > 0 > cash Flow > change In Working Capital
-2278563
Annuals > 0 > cash Flow > cash From Operations
-48556690
Annuals > 0 > cash Flow > capital Expenditures
46871
Annuals > 0 > cash Flow > cash From Investing
52364354
Annuals > 0 > cash Flow > cash From Financing
386446
Annuals > 0 > cash Flow > net Change In Cash
5608036
Annuals > 0 > ratios > PE
-0.7818302033185469
Annuals > 0 > ratios > PB
1.2087646075644831
Annuals > 0 > ratios > ROE
-75.00386340447648
Annuals > 0 > ratios > ROA
-60.596339123273715
Annuals > 0 > ratios > FCF
-48603561
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-293.1651738052585
Annuals > 0 > health Score
35
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
63089
Annuals > 1 > income Statement > cost Of Revenue
532262
Annuals > 1 > income Statement > gross Profit
-469173
Annuals > 1 > income Statement > operating Expenses
44438923
Annuals > 1 > income Statement > operating Income
-44908096
Annuals > 1 > income Statement > interest Expense
35628
Annuals > 1 > income Statement > pretax Income
-42667529
Annuals > 1 > income Statement > net Income
-42667529
Annuals > 1 > income Statement > eps
-0.7766185402850379
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
54940137
Annuals > 1 > income Statement > income Tax Expense
-1
Annuals > 1 > income Statement > EBITDA
-42064121
Annuals > 1 > income Statement > operating Margin
-71182.13317694051
Annuals > 1 > income Statement > total Other Income Expense Net
2240567
Annuals > 1 > balance Sheet > cash
12767943
Annuals > 1 > balance Sheet > short Term Investments
77504518
Annuals > 1 > balance Sheet > receivables
3791564
Annuals > 1 > balance Sheet > inventories
11367807
Annuals > 1 > balance Sheet > total Current Assets
109468481
Annuals > 1 > balance Sheet > property Plant Equipment
1361243
Annuals > 1 > balance Sheet > total Assets
120208552
Annuals > 1 > balance Sheet > payables
5102700
Annuals > 1 > balance Sheet > short Term Debt
374329
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
17626822
Annuals > 1 > balance Sheet > equity
102581730
Annuals > 1 > cash Flow > net Income
-42667529
Annuals > 1 > cash Flow > depreciation
567780
Annuals > 1 > cash Flow > change In Working Capital
1003585
Annuals > 1 > cash Flow > cash From Operations
-37812966
Annuals > 1 > cash Flow > capital Expenditures
81100
Annuals > 1 > cash Flow > cash From Investing
-17696616
Annuals > 1 > cash Flow > cash From Financing
52986269
Annuals > 1 > cash Flow > net Change In Cash
-3497412
Annuals > 1 > ratios > PE
-0.7766185402850379
Annuals > 1 > ratios > PB
0.6748236027994459
Annuals > 1 > ratios > ROE
-41.59369217111078
Annuals > 1 > ratios > ROA
-35.49458694086923
Annuals > 1 > ratios > FCF
-37894066
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-600.6445814642806
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
627008
Annuals > 2 > income Statement > gross Profit
-627008
Annuals > 2 > income Statement > operating Expenses
54439478
Annuals > 2 > income Statement > operating Income
-55066486
Annuals > 2 > income Statement > interest Expense
45250
Annuals > 2 > income Statement > pretax Income
-30987568
Annuals > 2 > income Statement > net Income
-30987568
Annuals > 2 > income Statement > eps
-0.7009513441191798
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
44207873
Annuals > 2 > income Statement > income Tax Expense
-2442297
Annuals > 2 > income Statement > EBITDA
-30313003
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
24078917
Annuals > 2 > balance Sheet > cash
16265354
Annuals > 2 > balance Sheet > short Term Investments
65543106
Annuals > 2 > balance Sheet > receivables
1432087
Annuals > 2 > balance Sheet > inventories
0
Annuals > 2 > balance Sheet > total Current Assets
97411058
Annuals > 2 > balance Sheet > property Plant Equipment
1640728
Annuals > 2 > balance Sheet > total Assets
102399660
Annuals > 2 > balance Sheet > payables
4987538
Annuals > 2 > balance Sheet > short Term Debt
369376
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
14050220
Annuals > 2 > balance Sheet > equity
88349440
Annuals > 2 > cash Flow > net Income
-29484611
Annuals > 2 > cash Flow > depreciation
596597
Annuals > 2 > cash Flow > change In Working Capital
-9773517
Annuals > 2 > cash Flow > cash From Operations
-33742817
Annuals > 2 > cash Flow > capital Expenditures
162391
Annuals > 2 > cash Flow > cash From Investing
19358095
Annuals > 2 > cash Flow > cash From Financing
1937459
Annuals > 2 > cash Flow > net Change In Cash
-9984640
Annuals > 2 > ratios > PE
-0.7009513441191798
Annuals > 2 > ratios > PB
0.6304728131836489
Annuals > 2 > ratios > ROE
-35.073870304101526
Annuals > 2 > ratios > ROA
-30.261397352295898
Annuals > 2 > ratios > FCF
-33905208
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
791258
Annuals > 3 > income Statement > gross Profit
-791258
Annuals > 3 > income Statement > operating Expenses
55568732
Annuals > 3 > income Statement > operating Income
-56359990
Annuals > 3 > income Statement > interest Expense
24769
Annuals > 3 > income Statement > pretax Income
-53933859
Annuals > 3 > income Statement > net Income
-53933859
Annuals > 3 > income Statement > eps
-1.2955535115155248
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
41629974
Annuals > 3 > income Statement > income Tax Expense
24768
Annuals > 3 > income Statement > EBITDA
-53113322
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
2426131
Annuals > 3 > balance Sheet > cash
26249995
Annuals > 3 > balance Sheet > short Term Investments
57162266
Annuals > 3 > balance Sheet > receivables
1282177
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
95677896
Annuals > 3 > balance Sheet > property Plant Equipment
1682451
Annuals > 3 > balance Sheet > total Assets
125139120
Annuals > 3 > balance Sheet > payables
1685037
Annuals > 3 > balance Sheet > short Term Debt
366171
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
19858124
Annuals > 3 > balance Sheet > equity
105280996
Annuals > 3 > cash Flow > net Income
-45630059
Annuals > 3 > cash Flow > depreciation
669434
Annuals > 3 > cash Flow > change In Working Capital
1538218
Annuals > 3 > cash Flow > cash From Operations
-39936750
Annuals > 3 > cash Flow > capital Expenditures
37778
Annuals > 3 > cash Flow > cash From Investing
-25950885
Annuals > 3 > cash Flow > cash From Financing
61577266
Annuals > 3 > cash Flow > net Change In Cash
281314
Annuals > 3 > ratios > PE
-1.2955535115155248
Annuals > 3 > ratios > PB
0.4982263583448621
Annuals > 3 > ratios > ROE
-51.22848476851416
Annuals > 3 > ratios > ROA
-43.0991196038457
Annuals > 3 > ratios > FCF
-39974528
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.18000000029361177
Valuation > metrics > PB
1.5465197596525126
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-27.02655895063385
Profitability > metrics > ROA
-19.31883672172072
Profitability > metrics > Net Margin
-514.5232480067142
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.4362271188753277
Risk > metrics > Interest Coverage
-660.004457134898
Risk > final Score
-2580
Risk > verdict
High
Liquidity > metrics > Current Ratio
6.681557087626316
Liquidity > metrics > Quick Ratio
6.147665882430227
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
15
Prev Profitabilities > 2
30
Prev Risks > 0
-15341
Prev Risks > 1
-12671
Prev Risks > 2
-8112
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-16T22:49:38.613Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-19
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.1586
Earnings History > 0 > eps Difference
0.1586
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-26
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.18
Earnings History > 1 > eps Estimate
-0.1511
Earnings History > 1 > eps Difference
-0.0289
Earnings History > 1 > surprise Percent
-19.1264
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-07
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.21
Earnings History > 2 > eps Estimate
-0.1729
Earnings History > 2 > eps Difference
-0.0371
Earnings History > 2 > surprise Percent
-21.4575
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-07
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.13
Earnings History > 3 > eps Estimate
-0.17
Earnings History > 3 > eps Difference
0.04
Earnings History > 3 > surprise Percent
23.5294
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-20
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.09
Earnings History > 4 > eps Estimate
-0.2513
Earnings History > 4 > eps Difference
0.1613
Earnings History > 4 > surprise Percent
64.1862
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-08
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
-0.3
Earnings History > 5 > eps Estimate
-0.25
Earnings History > 5 > eps Difference
-0.05
Earnings History > 5 > surprise Percent
-20
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-08
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
-0.24
Earnings History > 6 > eps Estimate
-0.2
Earnings History > 6 > eps Difference
-0.04
Earnings History > 6 > surprise Percent
-20
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-08
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
-0.17
Earnings History > 7 > eps Estimate
-0.22
Earnings History > 7 > eps Difference
0.05
Earnings History > 7 > surprise Percent
22.7273
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-21
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
-0.27
Earnings History > 8 > eps Estimate
-0.18
Earnings History > 8 > eps Difference
-0.09
Earnings History > 8 > surprise Percent
-50
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-01
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
-0.13
Earnings History > 9 > eps Estimate
-0.24
Earnings History > 9 > eps Difference
0.11
Earnings History > 9 > surprise Percent
45.8333
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-10
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
-0.14
Earnings History > 10 > eps Estimate
-0.31
Earnings History > 10 > eps Difference
0.17
Earnings History > 10 > surprise Percent
54.8387
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-11
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
-0.25
Earnings History > 11 > eps Estimate
-0.27
Earnings History > 11 > eps Difference
0.02
Earnings History > 11 > surprise Percent
7.4074
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-22
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
-0.18
Earnings History > 12 > eps Estimate
-0.25
Earnings History > 12 > eps Difference
0.07
Earnings History > 12 > surprise Percent
28
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-09
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
-0.18
Earnings History > 13 > eps Estimate
-0.32
Earnings History > 13 > eps Difference
0.14
Earnings History > 13 > surprise Percent
43.75
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-05
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
0.01
Earnings History > 14 > eps Estimate
-0.3
Earnings History > 14 > eps Difference
0.31
Earnings History > 14 > surprise Percent
103.3333
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-12
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
-0.32
Earnings History > 15 > eps Estimate
-0.32
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
0
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-24
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
-0.32
Earnings History > 16 > eps Estimate
-0.22
Earnings History > 16 > eps Difference
-0.1
Earnings History > 16 > surprise Percent
-45.4545
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-05
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
EUR
Earnings History > 17 > eps Actual
-0.27
Earnings History > 17 > eps Estimate
-0.31
Earnings History > 17 > eps Difference
0.04
Earnings History > 17 > surprise Percent
12.9032
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-05
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
EUR
Earnings History > 18 > eps Actual
-0.33
Earnings History > 18 > eps Estimate
-0.2
Earnings History > 18 > eps Difference
-0.13
Earnings History > 18 > surprise Percent
-65
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-12
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
EUR
Earnings History > 19 > eps Actual
-0.18
Earnings History > 19 > eps Estimate
-0.23
Earnings History > 19 > eps Difference
0.05
Earnings History > 19 > surprise Percent
21.7391
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-25
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
EUR
Earnings History > 20 > eps Actual
-0.32
Earnings History > 20 > eps Estimate
-0.22
Earnings History > 20 > eps Difference
-0.1
Earnings History > 20 > surprise Percent
-45.4545
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-10-29
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
EUR
Earnings History > 21 > eps Actual
-0.25
Earnings History > 21 > eps Estimate
-0.32
Earnings History > 21 > eps Difference
0.07
Earnings History > 21 > surprise Percent
21.875
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-07-30
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
EUR
Earnings History > 22 > eps Actual
-0.38
Earnings History > 22 > eps Estimate
-0.38
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
0
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-05-21
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
EUR
Earnings History > 23 > eps Actual
-0.32
Earnings History > 23 > eps Estimate
-0.53
Earnings History > 23 > eps Difference
0.21
Earnings History > 23 > surprise Percent
39.6226
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2019-12-31
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
EUR
Earnings History > 24 > eps Actual
-0.52
Earnings History > 24 > eps Estimate
-0.6
Earnings History > 24 > eps Difference
0.08
Earnings History > 24 > surprise Percent
13.3333
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-11-06
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
EUR
Earnings History > 25 > eps Actual
-0.56
Earnings History > 25 > eps Estimate
-0.51
Earnings History > 25 > eps Difference
-0.05
Earnings History > 25 > surprise Percent
-9.8039
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-08-14
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
EUR
Earnings History > 26 > eps Actual
-0.59
Earnings History > 26 > eps Estimate
-0.47
Earnings History > 26 > eps Difference
-0.12
Earnings History > 26 > surprise Percent
-25.5319
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-05-23
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
BeforeMarket
Earnings History > 27 > currency
EUR
Earnings History > 27 > eps Actual
-0.38
Earnings History > 27 > eps Estimate
-0.51
Earnings History > 27 > eps Difference
0.13
Earnings History > 27 > surprise Percent
25.4902
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2019-03-28
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
BeforeMarket
Earnings History > 28 > currency
EUR
Earnings History > 28 > eps Actual
-0.39
Earnings History > 28 > eps Estimate
-0.36
Earnings History > 28 > eps Difference
-0.03
Earnings History > 28 > surprise Percent
-8.3333
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-11-21
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
BeforeMarket
Earnings History > 29 > currency
EUR
Earnings History > 29 > eps Actual
-0.26
Earnings History > 29 > eps Estimate
-0.36
Earnings History > 29 > eps Difference
0.1
Earnings History > 29 > surprise Percent
27.7778
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-08-09
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
BeforeMarket
Earnings History > 30 > currency
EUR
Earnings History > 30 > eps Actual
-0.1
Earnings History > 30 > eps Estimate
-0.34
Earnings History > 30 > eps Difference
0.24
Earnings History > 30 > surprise Percent
70.5882
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-05-17
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
BeforeMarket
Earnings History > 31 > currency
EUR
Earnings History > 31 > eps Actual
-0.4
Earnings History > 31 > eps Estimate
-0.28
Earnings History > 31 > eps Difference
-0.12
Earnings History > 31 > surprise Percent
-42.8571
Earnings History > 32 > period
2017-12-31
Earnings History > 32 > report Date
2018-03-29
Earnings History > 32 > date
2017-12-31
Earnings History > 32 > before After Market
BeforeMarket
Earnings History > 32 > currency
EUR
Earnings History > 32 > eps Actual
-2.16
Earnings History > 32 > eps Estimate
-0.25
Earnings History > 32 > eps Difference
-1.91
Earnings History > 32 > surprise Percent
-764
Earnings History > 33 > period
2017-09-30
Earnings History > 33 > report Date
2017-12-21
Earnings History > 33 > date
2017-09-30
Earnings History > 33 > before After Market
AfterMarket
Earnings History > 33 > currency
EUR
Earnings History > 33 > eps Actual
-0.14
Earnings History > 33 > eps Estimate
-0.2
Earnings History > 33 > eps Difference
0.06
Earnings History > 33 > surprise Percent
30
Earnings History > 34 > period
2017-03-31
Earnings History > 34 > report Date
2017-05-04
Earnings History > 34 > date
2017-03-31
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
EUR
Earnings History > 34 > eps Actual
-0.16
Earnings History > 34 > eps Estimate
0
Earnings History > 34 > eps Difference
-0.16
Earnings History > 34 > surprise Percent
-
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase III clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; for the treatment of anti-neutrophil cytoplasm antibody associated vasculitis, a rare and life-threatening autoimmune disease that is in Phase II trial; to treat pyoderma gangraenosum, a chronic inflammatory skin disorder that is in Phase IIa exploratory study; and for the treatment of PD-1/PD-L1 inhibitor resistant/refractory locally advanced or metastatic cutaneous squamous cell carcinoma that is in Phase II clinical development stage. The company develops INF904, an oral, small molecule drug candidate for the chronic inflammatory and autoimmune diseases; IFX002 that is in pre-clinical development stage for the treatment of chronic inflammation and autoimmune diseases; and Gohibic (vilobelimab) for the treatment of COVID-19 and broader ARDS. It has co-development agreement with Beijing Defengrei Biotechnology Co. Ltd.; and clinical trial collaboration and supply agreement with Merck & Co. Inc. InflaRx N.V. was formerly known as Fireman B.V. and changed its name to InflaRx N.V. in 2017. The company was founded in 2007 and is headquartered in Jena, Germany.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AInflaRx N.V. (NASDAQ:IFRX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
12/17/2025
InflaRx N.V. (NASDAQ:IFRX) Receives Consensus Rating of "Moderate Buy" from Analysts MarketBeat
Read more →InflaRx (NASDAQ:IFRX) Downgraded to "Hold" Rating by Leerink Partnrs MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$11.6284
Analyst Picks
Strong Buy
5
Buy
1
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 24.00% of the total shares of InflaRx N.V.
1.
Suvretta Capital Management, LLC(9.5708%)
since
2025/06/30
2.
683 Capital Management LLC(3.6533%)
since
2025/06/30
3.
RA Capital Management, LLC(2.9126%)
since
2025/06/30
4.
Eversept Partners, LLC(2.4214%)
since
2025/06/30
5.
Woodline Partners LP(1.1089%)
since
2025/06/30
6.
Ikarian Capital, LLC(1.0406%)
since
2025/06/30
7.
Morgan Stanley - Brokerage Accounts(1.0242%)
since
2025/06/30
8.
Adage Capital Partners Gp LLC(0.4887%)
since
2025/06/30
9.
Dafna Capital Management LLC(0.2952%)
since
2025/06/30
10.
BOOTHBAY FUND MANAGEMENT, LLC(0.2333%)
since
2025/06/30
11.
UBS O'Connor LLC(0.2214%)
since
2025/06/30
12.
Squarepoint Ops LLC(0.2156%)
since
2025/06/30
13.
Commonwealth Equity Services Inc(0.2126%)
since
2025/06/30
14.
Virtu Financial LLC(0.0892%)
since
2025/06/30
15.
GSA Capital Partners LLP(0.0855%)
since
2025/06/30
16.
A4Investments SICAV SIF ACCI IlanaA2EURH(0.0758%)
since
2025/08/31
17.
Birchview Capital, LP(0.0738%)
since
2025/06/30
18.
Geode Capital Management, LLC(0.0645%)
since
2025/06/30
19.
Fidelity Nasdaq Composite Index(0.0645%)
since
2025/07/31
20.
HRT FINANCIAL LLC(0.0643%)
since
2025/06/30
21.
SIMPLEX TRADING, LLC(0.038%)
since
2025/06/30
22.
CIBC World Markets Inc.(0.0369%)
since
2025/06/30
23.
Azimut Trend(0.0033%)
since
2025/06/30
24.
AZ Fd1 AZ Allc Global Agsv A-AZ USD C(0.0033%)
since
2025/07/31
25.
Azimut Trading(0.0004%)
since
2025/06/30
26.
Azimut Strategic Trend(0.0003%)
since
2025/06/30
27.
Azimut Scudo(0.0001%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.1586
Date
2025-09-30
EPS Actual
-0.18
EPS Estimate
-0.1511
EPS Difference
-0.0289
Surprise Percent
-19.1264%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.